Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-005978-79Phase 3Completed
Phase 3 trial of benzocaine in acute pharyngitis (2 arms), sponsored by MCM Klosterfrau Vertriebsgesellschaft mbH. Primary endpoint: Responder rate for pain reduction after first lozenge/pastille. Started Aug 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-005978-79.